GemiFinance
Business

Blood-testing startup Theranos reported to be closing

NEW YORK – The once-heralded blood-testing startup Theranos is shutting down, based on a media report.

Theranos was struggle to sell itself and it’s now hoping to pay unsecured creditors its remaining cash around $5 million while in the upcoming months, depending on a text The Wall Street Journal obtained that CEO David Taylor transported to shareholders.

 
The article you requested is no longer situated on BostonHerald.com.
 
» Click here to evaluate this informative article from the Associated Press’ archive.

Related Articles

Byte of history: Considered one of 1st Apple computers to become sold

Blood-testing startup Theranos supposedly closing

Rare Apple-1 computer, possibly worth $800K-plus, for sale

Related posts

Asian shares mixed as Trump orders new tariffs on China

admin

While using fall of an kingmaker, CBS is punished on Wall Street

admin

MBTA’s pension rides sell to big returns

admin

Leave a Comment

Skip to toolbar